Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Testis cancer.

Mitchell H Sokoloff1, Geoffrey F Joyce, Matthew Wise

  • 1Section of Urologic Oncology, Division of Urology and Renal Transplantation, Department of Surgery, Oregon Health and Sciences University, 3181 Southwest Sam Jackson Park Road, Portland, OR 97239, USA.

The Journal of Urology
|May 19, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Editorial Commentary.

Urology practice·2026
Same author

An Overview of Farm Investigation Findings Associated with Outbreaks of Shiga Toxin-Producing Escherichia coli Infections Linked to Leafy Greens: 2009-2021.

Journal of food protection·2025
Same author

Genetic Diversity in <i>Salmonella enterica</i> in Outbreaks of Foodborne and Zoonotic Origin in the USA in 2006-2017.

Microorganisms·2024
Same author

Diagnoses and Treatment of Behavioral and Psychological Symptoms of Dementia Among Racially and Ethnically Diverse Persons Living with Dementia.

Journal of Alzheimer's disease : JAD·2024
Same author

Trends in Incident Dementia Diagnosis Before and After Medicare Risk Adjustment.

JAMA network open·2023
Same author

Editorial Commentary.

Urology practice·2023
Same journal

Endourology and Nephrolithiasis.

The Journal of urology·2026
Same journal

With great cost comes great responsibility: who will own the rising costs of bladder cancer care?

The Journal of urology·2026
Same journal

Phentermine/Topiramate in Obese, Diabetic Uric Acid Stone Formers: An Open-Label Randomized Feasibility Trial.

The Journal of urology·2026
Same journal

Letter: Is This the End of the "Letter to the Editor"?

The Journal of urology·2026
Same journal

Editorial Comment.

The Journal of urology·2026
Same journal

Uro-Science.

The Journal of urology·2026
See all related articles

Testis cancer incidence rose 46% in the US from 1975-2001, with improved survival rates. Despite shifts to active surveillance and reduced hospitalizations, the economic burden of testis cancer is increasing.

Area of Science:

  • Oncology
  • Health Economics
  • Epidemiology

Background:

  • Testis cancer incidence has been increasing in the United States.
  • Understanding the economic impact and healthcare resource utilization is crucial for public health planning.

Purpose of the Study:

  • To quantify the burden of testis cancer in the US.
  • To identify trends in incidence, treatment, and healthcare resource use.
  • To estimate the economic impact of testis cancer.

Main Methods:

  • Utilized previously described analytical methods to analyze trends.
  • Examined data on testis cancer incidence, treatment patterns, and healthcare expenditures.
  • Calculated economic impact based on medical expenditures and work hours missed.

Related Experiment Videos

Main Results:

  • Testis cancer incidence increased by 46% between 1975 and 2001.
  • Survival rates improved to 95.9%, with a shift towards active surveillance and fewer advanced-stage diagnoses.
  • Annual medical expenditures for testis cancer reached $21.8 million in 2000, a 10% increase from 1994, despite decreased hospitalization rates.

Conclusions:

  • The annual cost of testis cancer is approximately $21.8 million.
  • The economic burden of testis cancer is increasing over time.
  • This rise in cost occurs despite treatment shifts towards active surveillance and reduced hospitalizations.